TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Telomir Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.04−0.01 (-0.95%)
Close on Oct 19, 2026
- Market cap
- $63.27M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Telomir Pharmaceuticals has not reported a dividend
No dividend per share appears in Telomir Pharmaceuticals's annual filings since fiscal 2021.